When delivered at the same molar dose, bioequivalence of a drug product is attained if the extent and rate of absorption are not statistically significantly different from those of the reference product. Bioequivalence studies examine two medications or two formulations of the same drug to show that their bioavailability and PK/PD parameters are substantially comparable. These studies are frequently conducted for generic medications or when a drug's composition is altered during development.